Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1436)	9/27/2002 3:41:02 AM
From: mopgcw	Read Replies (1) \| Respond to of 2243

>> ...there's tons of enthusiasm coming from the 286 clinical investigators. It may be a GREAT investment, but I determined that it's not my type of company. I know I am too simplistic here, but I kind of think 286, 199 and 19781 are worth $10 a share, regardless of how they found 'em. And they still own 100% I think. >>you have at most (1) the insulin sensitizers, and (2) anything that has come out of academic labs at U. Arizona. But isn't that more than what has come out of most of these types of efforts? I agree the hype on these efforts can be (is?) quite misleading. I have the gnsc/vgnx scars to prove it.